The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2015
|
| DOI | 10.1002/14651858.cd011437.pub2 |
| Pubmed ID | |
| Authors |
David JW Evans, Kayleigh M Kew, Debbie E Anderson, Anne C Boyter |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 9% |
| Mexico | 2 | 9% |
| Australia | 1 | 5% |
| Ecuador | 1 | 5% |
| United States | 1 | 5% |
| Unknown | 15 | 68% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 64% |
| Practitioners (doctors, other healthcare professionals) | 5 | 23% |
| Science communicators (journalists, bloggers, editors) | 2 | 9% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 198 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 196 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 33 | 17% |
| Student > Bachelor | 19 | 10% |
| Researcher | 17 | 9% |
| Other | 11 | 6% |
| Student > Ph. D. Student | 11 | 6% |
| Other | 29 | 15% |
| Unknown | 78 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 27% |
| Nursing and Health Professions | 22 | 11% |
| Psychology | 12 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Economics, Econometrics and Finance | 4 | 2% |
| Other | 11 | 6% |
| Unknown | 86 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2016.
All research outputs
#1,679,051
of 26,222,667 outputs
Outputs from Cochrane database of systematic reviews
#3,399
of 13,248 outputs
Outputs of similar age
#19,891
of 275,143 outputs
Outputs of similar age from Cochrane database of systematic reviews
#78
of 275 outputs
Altmetric has tracked 26,222,667 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,248 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,143 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 275 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.